Clinical Trial: Monovision for the Treatment of Diplopia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Monovision for Treatment of Diplopia

Brief Summary:

PURPOSE:

The purpose of this study is to quantitatively assess the efficacy of monovision correction in the treatment of acquired small angle binocular diplopia in adult patients.

METHOD:

Twenty patients with symptomatic diplopia were enrolled in a prospective treatment trial. All had stable deviations of 10 prism diopters or less for over three months. Each received monovision spectacles and/ or contact lenses with distance correction in the dominant eye. Half received a +3.00 diopter (D) add and the others received +2.50 D. The validated and standardized Diplopia Questionnaire and Amblyopia and Strabismus Questionnaire (ASQE) were used to quantify the efficacy of monovision correction for diplopia by measuring the functional impact on vision-specific quality of life.


Detailed Summary:
Sponsor: Mount Sinai Hospital, Canada

Current Primary Outcome: Patients satisfaction with monovision was measured by standardized diplopia questionnaire and results reported in statistical terms on multiple measures tested on the questionnaire. [ Time Frame: 2 years ]

To determine whether monovision correction was useful for the correction of small angle deviations in strabismic patients


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Mount Sinai Hospital, Canada

Dates:
Date Received: August 11, 2011
Date Started: January 2009
Date Completion:
Last Updated: August 30, 2011
Last Verified: January 2011